Per-Particle Cardiovascular Risk of Lipoprotein(a) vs Non-Lp(a) Apolipoprotein B-Containing Lipoproteins

Affiliations

¹ TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: nmarston@bwh.harvard.edu.
² TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
³ Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; University of Warmia and Mazury, Olsztyn, Poland.
⁴ Cardiovascular Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Free article

Nicholas A Marston et al. J Am Coll Cardiol. 2024.

Free article

. 2024 Jan 23;83(3):470-472.

doi: 10.1016/j.jacc.2023.09.836.

¹ TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: nmarston@bwh.harvard.edu.
² TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
³ Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; University of Warmia and Mazury, Olsztyn, Poland.
⁴ Cardiovascular Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

No abstract available

Comment in

Particle Number and Characteristics of Lipoprotein(a), LDL, and apoB: Perspectives on Contributions to ASCVD.
Tsimikas S, Bittner V. Tsimikas S, et al. J Am Coll Cardiol. 2024 Jan 23;83(3):396-400. doi: 10.1016/j.jacc.2023.11.008. J Am Coll Cardiol. 2024. PMID: 38233013 No abstract available.